Note: Ingredients listed on restricted chemical lists
EC/CAS
203-473-3/107-21-1
Name of the chemical
Ethane-1,2-diol
Concentration
45 - 50
General Information
Version
S10027-EU01EN
Revision date
2023-11-24
Product name
CCI L265 premix
1.2.1 Relevant identified uses
Industrial use,Professional use
Emergency telephone
+353 1 809 2566, +353 1 809 2166
Icons in SDS
Company Information
company name
CCI Manufacturing Germany GmbH
e-mail address of the competent person responsible for the Safety Data Sheet
cmg.info@cci-corporation.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H302, H373
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture
Hazard pictograms
GHS07 GHS08
Signal word
Warning Page
Contains
ethanediol; ethylene glycol
Hazard statements
H302 - Harmful if swallowed. H373 - May cause damage to organs (kidneys) through prolonged or repeated exposure (oral).
Precautionary statements
P260 - Do not breathe vapours. P264 - Wash hands, forearms and face thoroughly after handling. P270 - Do not eat, drink or smoke when using this product. P314 - Get medical advice/attention if you feel unwell. P501 - Dispose of contents and container to an approved waste disposal plant.
Results of PBT and vPvB assessment
Not applicable. The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No. 1272/2008 [CLP]Mixtures/Substances: SDS EU > 2015: According to Regulation (EU) 2015/830, 2020/878 (REACH Annex II) Acute Tox. 4 (Oral) H302 STOT RE 2 H373 Full text of H- and EUH-statements: see section 16